Ignite Creation Date:
2024-05-06 @ 4:15 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04921345
Status:
RECRUITING
Last Update Posted:
2023-04-07
First Post:
2021-06-04
Brief Title:
Pharmacokinetics Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis
Sponsor:
Galderma RD
Organization:
Galderma RD
Organization Data
Organization:
Galderma RD
Class:
INDUSTRY
Study ID:
RD06SPR118126
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Galderma RD
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None